236 related articles for article (PubMed ID: 22926568)
1. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
Vu DH; Bolhuis MS; Koster RA; Greijdanus B; de Lange WC; van Altena R; Brouwers JR; Uges DR; Alffenaar JW
Antimicrob Agents Chemother; 2012 Nov; 56(11):5758-63. PubMed ID: 22926568
[TBL] [Abstract][Full Text] [Related]
2. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
Bolhuis MS; van Altena R; van Hateren K; de Lange WC; Greijdanus B; Uges DR; Kosterink JG; van der Werf TS; Alffenaar JW
Antimicrob Agents Chemother; 2013 Aug; 57(8):3676-80. PubMed ID: 23689722
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.
Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():42-7. PubMed ID: 23973533
[TBL] [Abstract][Full Text] [Related]
5. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
[TBL] [Abstract][Full Text] [Related]
6. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
[TBL] [Abstract][Full Text] [Related]
8. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
10. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children.
Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M
Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116
[TBL] [Abstract][Full Text] [Related]
11. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis.
Padayatchi N; Mac Kenzie WR; Hirsch-Moverman Y; Feng PJ; Villarino E; Saukkonen J; Heilig CM; Weiner M; El-Sadr WM
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1582-7. PubMed ID: 23131255
[TBL] [Abstract][Full Text] [Related]
12. Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
Bolhuis MS; van Altena R; van Soolingen D; de Lange WC; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
Eur Respir J; 2013 Dec; 42(6):1614-21. PubMed ID: 23520311
[TBL] [Abstract][Full Text] [Related]
13. Bone penetration of linezolid in osteoarticular tuberculosis patients of China.
Wen S; Zhang T; Yu X; Dong W; Lan T; Fan J; Xue Y; Wang F; Dong L; Qin S; Huang H
Int J Infect Dis; 2021 Feb; 103():364-369. PubMed ID: 33278623
[TBL] [Abstract][Full Text] [Related]
14. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
15. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study.
Davies Forsman L; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar JW; Mansjö M; Hoffner S; Xu B; Schön T; Bruchfeld J
BMJ Open; 2018 Oct; 8(9):e023899. PubMed ID: 30287613
[TBL] [Abstract][Full Text] [Related]
18. Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis.
Parsons TL; Marzinke MA; Hoang T; Bliven-Sizemore E; Weiner M; Mac Kenzie WR; Dorman SE; Dooley KE
Antimicrob Agents Chemother; 2014 Nov; 58(11):6747-57. PubMed ID: 25182637
[TBL] [Abstract][Full Text] [Related]
19. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot.
la Marca G; Villanelli F; Malvagia S; Ombrone D; Funghini S; De Gaudio M; Fallani S; Cassetta MI; Novelli A; Chiappini E; de Martino M; Galli L
J Pharm Biomed Anal; 2012; 67-68():86-91. PubMed ID: 22559989
[TBL] [Abstract][Full Text] [Related]
20. Dried blood spots: a new tool for tuberculosis treatment optimization.
Vu DH; Alffenaar JW; Edelbroek PM; Brouwers JR; Uges DR
Curr Pharm Des; 2011; 17(27):2931-9. PubMed ID: 21834763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
